Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
SEK 50.8
(-4.87%)
SEK 50.8
(-4.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -101.21 Million | -85.79 Million | -55.62 Million | -58.38 Million | -51.3 Million | -47.4 Million |
| Net Income | -123.06 Million | -65.8 Million | -44.57 Million | -71.91 Million | -47.2 Million | -39.41 Million |
| Depreciation & Amortization | 816 Thousand | 816 Thousand | 816 Thousand | 816 Thousand | 816 Thousand | 816 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 18.95 Million | 11.84 Million | 7.39 Million | -2.32 Million | -1.47 Million | 1.13 Million |
| Other non-cash items | 2.07 Million | -32.64 Million | -19.25 Million | 15.03 Million | -3.43 Million | -9.94 Million |
| Investing Cash Flow | -4.14 Million | -1000.00 | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1000.00 | - | - | - | - |
| Financing Cash Flow | 96.51 Million | 1.88 Million | 91 Thousand | 1.76 Million | - | 428.95 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -20 Thousand | - | - | - | - |
| Common Stock Issuance | 96.51 Million | 1.9 Million | 91 Thousand | 1.76 Million | - | 439.14 Million |
| Other Financing Activities | 96.51 Million | -20 Thousand | 91 Thousand | 1.76 Million | - | -10.18 Million |
| Accounts receivables | -9.3 Million | 7.15 Million | 4.33 Million | -4.61 Million | -2.7 Million | 1.13 Million |
| Accounts payables | 28.26 Million | 4.68 Million | - | - | - | - |
| Inventory | -28.26 Million | -4.68 Million | - | - | - | - |
| Other working capital | 28.26 Million | 4.68 Million | 3.06 Million | 2.28 Million | 1.22 Million | 1000.00 |
| Cash at beginning of period | 335.84 Million | 386.75 Million | 423.43 Million | 495.18 Million | 542.17 Million | 158.27 Million |
| Cash at end of period | 329.06 Million | 335.84 Million | 386.75 Million | 423.43 Million | 495.18 Million | 542.17 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 2.07 Million | 33 Million | 18.84 Million | -15.12 Million | 4.31 Million | 2.35 Million |
| Net cash flow / Change in cash | -6.77 Million | -50.91 Million | -36.68 Million | -71.75 Million | -46.98 Million | 383.89 Million |
| Free Cash Flow | -101.21 Million | -85.79 Million | -55.62 Million | -58.38 Million | -51.3 Million | -47.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.27 Million | -29.79 Million | -123.06 Million | -40.89 Million | -33.71 Million | -30.95 Million |
| Depreciation & Amortization | 204 Thousand | 204 Thousand | 816 Thousand | 204 Thousand | 204 Thousand | 204 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.34 Million | 8.16 Million | 18.95 Million | 2.54 Million | 932 Thousand | 22.38 Million |
| Other non-cash items | -1.99 Million | -13.28 Million | 2.07 Million | 9.38 Million | 3.27 Million | -6.28 Million |
| Investing Cash Flow | - | - | -4.14 Million | -4.14 Million | 1000.00 | -1000.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.01 Million | - | 96.51 Million | - | 96 Million | 510 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.01 Million | - | 96.51 Million | -1000.00 | 96 Million | 510 Thousand |
| Other Financing Activities | 2.01 Million | - | 96.51 Million | - | 96 Million | 510 Thousand |
| Accounts receivables | 15.12 Million | -17.19 Million | -9.3 Million | -2.96 Million | -3.27 Million | 10.37 Million |
| Accounts payables | -11.77 Million | 25.35 Million | 28.26 Million | 5.51 Million | 4.2 Million | 12 Million |
| Inventory | - | - | -28.26 Million | -5.51 Million | - | - |
| Other working capital | -11.77 Million | 25.35 Million | 28.26 Million | 5.51 Million | -1000.00 | 2000.00 |
| Cash at beginning of period | 309.61 Million | 329.06 Million | 335.84 Million | 367.2 Million | 300.95 Million | 306.68 Million |
| Cash at end of period | 272.51 Million | 309.61 Million | 329.06 Million | 329.06 Million | 367.2 Million | 300.95 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -1.15 Million | 5.32 Million | 2.07 Million | -5.23 Million | -448 Thousand | 8.41 Million |
| Net cash flow / Change in cash | -37.1 Million | -19.44 Million | -6.77 Million | -38.14 Million | 66.25 Million | -5.72 Million |
| Free Cash Flow | -37.97 Million | -24.76 Million | -101.21 Million | -28.75 Million | -29.3 Million | -14.64 Million |
6263
2628
6953
4111
WINA
PHIA